Post-Transplant Cyclophosphamide (PTCy)-Based Haploidentical (Haplo) Donor vs. Calcineurin-Inhibitor (CNI)-Based Matched Related Donor (MRD) Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL)

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.824
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

ERRATUM: Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency Using Post-Transplantation Cyclophosphamide

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Dynamics of Immune Cell Reconstitution in Allogeneic Hematopoietic Cell Transplant Patients Receiving Post-Transplant Cyclophosphamide (PTCy)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Donor-Derived Myeloid Neoplasm Post Allogeneic Hematopoietic Cell Transplantation

Blood
BiochemistryImmunologyCell BiologyHematology
2017English

Modified Reduced Intensity Conditioning (RIC) of HLA-Haploidentical Related Hematopoietic Cell Transplantation (HAPLO-HCT) for Patients With Hematological Malignancies: Interim Analysis of an Age- And Risk-Adapted Phase II Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-Sct) With Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse After Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

No Evidence of Impact of Maraviroc on Outcome After Allogeneic Hematopoietic Stem Cell Transplant With Reduced Intensity Conditioning (RIC)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

How to Select Donor, Stem Cell Source, and Conditioning Regimen for Haploidentical Transplants With Post-Transplant Cyclophosphamide for Lymphoma: A Report of the Ebmt LWP

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy